HOME
|
CONTACT
|
PATIENT LOGIN
|
CLINIC LOGIN
|
FAQ
PATIENTS &
HEALTHY VOLUNTEERS
INVESTIGATORS
CROS / SPONSORS
CAREERS
TRIAL ALERTS
TRIALS SEARCH
HEALTH NEWS
RSS FEEDS
ABOUT TRIALS
LINK TO US
Site Listing
Please choose the site that is most convenient for you
Study Name: Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
9 locations found
1241.21.0003 Boehringer Ingelheim Investigational Site
Location: La Jolla, California
1241.21.0004 Boehringer Ingelheim Investigational Site
Location: San Francisco, California
1241.21.0011 Boehringer Ingelheim Investigational Site
Location: Palm Harbor, Florida
1241.21.0013 Boehringer Ingelheim Investigational Site
Location: Valparaiso, Indiana
1241.21.0008 Boehringer Ingelheim Investigational Site
Location: Springfield, Massachusetts
1241.21.0012 Boehringer Ingelheim Investigational Site
Location: Arlington, Texas
1241.21.0005 Boehringer Ingelheim Investigational Site
Location: Austin, Texas
1241.21.0007 Boehringer Ingelheim Investigational Site
Location: Dallas, Texas
1241.21.0010 Boehringer Ingelheim Investigational Site
Location: Houston, Texas